FSHR single nucleotide polymorphism frequencies in proven fathers and infertile men in Southeast Turkey.
The influence of FSH receptor (FSHR) variants on male infertility is not completely understood. The present investigation is the first screening study for SNP at nucleotide position -29 in the core promoter region and codon 680 in exon 10 of the FSHR and the effect of the serum levels of FSH on male infertility in Southeast Turkey. The SNPs in codon 680 and at position -29 of the FSHR gene were analyzed by PCR-RFLP technique in 240 men with proven fathers, and 270 infertile men (150 nonobstructive azoospermic and 120 severe oligozoospermic). The separate analysis for SNP at nucleotide position -29 did not show any difference in genotypic frequencies and serum FSH levels. The genotype distribution of SNP at position 680 was different but does not influence serum FSH levels. Together the two SNPs form four discrete haplotypes (A-Thr-Asn, G-Thr-Asn, A-Ala-Ser, and G-Ala-Ser) occurring in 10 combinations. A statistically significant difference in the allelic distribution of G-Asn/G-Ser and G-Ser/G-Ser genotype between proven fathers and infertile men but there were not any statistically significant difference in the overall frequency of the four FSHR haplotypes. We conclude that the FSHR haplotype does not associate with different serum FSH levels but it is differently distributed in proven fathers and infertile men.
Balkan
Mahmut
M
Department of Medical Biology and Genetics, Dicle University Medical Faculty, 21280 Diyarbakir, Turkey.
Gedik
Abdullah
A
Akkoc
Hasan
H
Izci Ay
Ozlem
O
Erdal
M Emin
ME
Isi
Hilmi
H
Budak
Turgay
T
D000483:Alleles; D003062:Codon / Q000235:genetics; D005220:Fathers; D005787:Gene Frequency / Q000235:genetics; D005838:Genotype; D006801:Humans; D007248:Infertility, Male / Q000235:genetics*; D008297:Male; D020641:Polymorphism, Single Nucleotide / Q000235:genetics*; D011962:Receptors, FSH / Q000097:blood / Q000235:genetics*; D014421:Turkey
D003062:Codon; D011962:Receptors, FSH
Mol Hum Reprod. 2002 Oct;8(10):893-9
12356937
Endocr Rev. 1997 Dec;18(6):739-73
9408742
Trends Endocrinol Metab. 2005 Oct;16(8):368-73
16126408
Fertil Steril. 2005 Aug;84(2):446-53
16084888
Clin Endocrinol (Oxf). 1999 Jul;51(1):97-9
10468971
Endocr J. 2009;56(7):859-65
19550076
Arch Androl. 2007 May-Jun;53(3):125-33
17612870
Gynecol Endocrinol. 2004 Jul;19(1):9-17
15625767
Eur J Endocrinol. 1998 Aug;139(2):145-7
9724066
Cell. 1995 Sep 22;82(6):959-68
7553856
Methods. 2000 May;21(1):83-97
10764609
Hemoglobin. 1982;6(1):27-36
7068433
Fertil Steril. 2003 Oct;80(4):986-92
14556822
Fertil Steril. 1998 Aug;70(2):326-31
9696229
J Clin Endocrinol Metab. 2000 Sep;85(9):3365-9
10999835
J Clin Endocrinol Metab. 1999 Feb;84(2):751-5
10022448
J Androl. 2005 Jul-Aug;26(4):494-9
15955888
Carcinogenesis. 2006 Jul;27(7):1502-6
16574671
Pharmacogenetics. 2004 May;14(5):285-93
15115914
Nucleic Acids Res. 1988 Feb 11;16(3):1215
3344216
Reprod Biomed Online. 2006 Dec;13(6):795-800
17169197
Andrologia. 2002 Jun;34(3):172-6
12059813
Hum Reprod Update. 2002 Sep-Oct;8(5):413-21
12398222
Andrologia. 2008 Dec;40(6):392-7
19032691
Reprod Biomed Online. 2007 Dec;15(6):643-58
18062861